Literature DB >> 24328014

Synchronous occurrence of primary malignant mixed müllerian tumor in ovary and uterus.

Tae Yeon Lee1, Chulmin Lee, Won Jun Choi, Ji Young Lee, Heung Yeol Kim.   

Abstract

Malignant mixed müllerian tumor (MMMT) arising from female internal genitalia is rare with the uterine corpus being the most prevalently affected site. It is even more rare when it occurs on both uterus and ovary at the same time. We describe a case of synchronized occurrence of MMMT on ovary and uterine adenosarcoma with review of literature.

Entities:  

Keywords:  Malignant mixed müllerian tumor; Ovary; Uterus

Year:  2013        PMID： 24328014      PMCID： PMC3784138          DOI： 10.5468/ogs.2013.56.4.269

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN： 2287-8572


  15 in total

1.  Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.

Authors:  A K Sood; J I Sorosky; M S Gelder; R E Buller; B Anderson; E J Wilkinson; J A Benda; L S Morgan
Journal:  Cancer       Date:  1998-05-01       Impact factor: 6.860

2.  Müllerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of müllerian mixed tumor.

Authors:  P B Clement; R E Scully
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature.

Authors:  P B Clement; R E Scully
Journal:  Hum Pathol       Date:  1990-04       Impact factor: 3.466

Review 4.  Carcinosarcoma of the ovary a review.

Authors:  Leigh A Cantrell; Linda Van Le
Journal:  Obstet Gynecol Surv       Date:  2009-10       Impact factor: 2.347

5.  A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study.

Authors:  G P Sutton; J A Blessing; H D Homesley; J H Malfetano
Journal:  Gynecol Oncol       Date:  1994-04       Impact factor: 5.482

6.  Carcinosarcoma of the ovary.

Authors:  D-A Silasi; J L Illuzzi; M G Kelly; T J Rutherford; G Mor; M Azodi; P E Schwartz
Journal:  Int J Gynecol Cancer       Date:  2007-04-19       Impact factor: 3.437

7.  Carcinosarcoma of the ovary: 19 years of prospective data from a single center.

Authors:  Ewan Brown; Moira Stewart; Tzyvia Rye; Awatif Al-Nafussi; Alistair R W Williams; Michael Bradburn; John Smyth; Hani Gabra
Journal:  Cancer       Date:  2004-05-15       Impact factor: 6.860

8.  Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study.

Authors:  J Tate Thigpen; John A Blessing; Koen DeGeest; Katherine Y Look; Howard D Homesley
Journal:  Gynecol Oncol       Date:  2004-05       Impact factor: 5.482

9.  Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary.

Authors:  Linda R Duska; Audrey Garrett; Gamal H Eltabbakh; Esther Oliva; Richard Penson; Arlan F Fuller
Journal:  Gynecol Oncol       Date:  2002-06       Impact factor: 5.482

10.  Ascitic fluid cytology in a case of metastatic malignant mixed mesodermal tumor of the ovary.

Authors:  J F Silverman; J Gardner; E W Larkin; J L Finley; H T Norris
Journal:  Acta Cytol       Date:  1986 Mar-Apr       Impact factor: 2.319
View more
  3 in total

Review 1.  Uterine Adenosarcoma: a Review.

Authors:  Michael J Nathenson; Vinod Ravi; Nicole Fleming; Wei-Lien Wang; Anthony Conley
Journal:  Curr Oncol Rep       Date:  2016-11       Impact factor: 5.075

2.  Synchronous uterine adenocarcinoma and leiomyosarcoma - a case study.

Authors:  Kamila Dudzik; Agnieszka Krzysteczko; Leon Kolny; Agnieszka Bąk; Ewelina Stawicka-Ociepka; Krzysztof Nowosielski
Journal:  Prz Menopauzalny       Date:  2017-04-26

3.  Bilateral synchronous ovarian tumours: an uncommon case and review of the literature.

Authors:  Emre Günakan; Yusuf A Tohma; Asuman N Haberal; Ali Ayhan
Journal:  Prz Menopauzalny       Date:  2018-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.